T1	Participants 368 412	Chinese patients with essential hypertension
T2	Participants 556 613	105 patients with mild or moderate essential hypertension
T3	Participants 979 1003	One hundred one patients
T4	Participants 1076 1173	No significant difference (all P values > 0.05) was found in baseline data between the two groups
T5	Participants 851 969	Only those patients who have finished 8 weeks of active treatment in both groups were included into the final analysis
